The treatment of acute heart failure(circulatory management) Yasuyuki SHIRAISHI 1 1Department of Cardiology Keio University School of Medicine pp.17-27
Published Date 2021/1/1
DOI https://doi.org/10.11477/mf.3102200829
  • Abstract
  • Look Inside
  • Reference

Heart failure is a significant public health burden, affecting more than 1.2 million adults in Japan, associated with high morbidity, mortality, impaired health status, and cost. Primarily, the hospitalization and acute-phase management of heart failure, especially of acute heart failure, presents challenges to health care systems while necessitating substantial efforts to achieve favorable outcomes. The treatment options for acute heart failure have remained relatively unchanged over past decades, however, recent studies have shown that the management of acute heart failure is “time sensitive” and suggested that treatment selection according to individual etiologies, triggers, and risk profiles could lead to better outcomes. Within this clinical context, it is of paramount importance that clinicians need to classify each patient by pathophysiological phenotypes, i.e. pulmonary/systemic congestion and tissue hypoperfusion, and to promptly provide appropriate interventions to stabilize the hemodynamics, following by evidence-based therapeutics for improving long-term outcomes of patients with heart failure.

Copyright © 2021, MEDICAL SCIENCES INTERNATIONAL, LTD. All rights reserved.


電子版ISSN 2186-7852 印刷版ISSN 1883-4833 メディカル・サイエンス・インターナショナル